Wird geladen...
Improved bioavailability of cromolyn sodium using inhaled PA101 delivered via eFlow® nebulizer
In 1960s, cromolyn sodium (CS) has been introduced as the first non-steroidal anti-inflammatory drug for the treatment of allergic and mast-cell driven diseases. Its applicability has been limited due to a poor bioavailability. Here we present pharmacokinetic data of a novel high concentration formu...
Gespeichert in:
| Veröffentlicht in: | Eur Clin Respir J |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Taylor & Francis
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7480408/ https://ncbi.nlm.nih.gov/pubmed/32944204 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20018525.2020.1809083 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|